Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,677.56
(
-0.57%
)
US TECH 100
24,008.40
(
-0.51%
)
Dow Jones
46,576.92
(
-0.89%
)
Brent Oil
103.70
(
3.03%
)
Bitcoin
71,760.13
(
-2.95%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 73654

Thursday, 02/26/2009 7:58:56 AM

Thursday, February 26, 2009 7:58:56 AM

Post# of 257253
Re: R7128 phase-2 trial design

Isn’t it odd that the actual design differs in so many respects from the intended design described in the 1/12/09 PR? I’m not sure whether having three trials arms with the 90mcg “half” Pegasys dose (including one arm that tests 90mcg Pegasys with the extra-high 1500mg BID dose of R7128) should be viewed as bullish or bearish for R7128.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now